Precursor Cell Lymphoblastic Leukemia-Lymphoma  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Precursor Cell Lymphoblastic Leukemia-Lymphoma
EMTP, NCT00590915: Erwinase Master Treatment Protocol

No Longer Available
N/A
US
Erwinia L-asparaginase, Erwinase
Phoenix Children's Hospital, Fisher Bioservices, Jazz Pharmaceuticals
Leukemia, Acute Lymphoblastic, Acute Lymphoid Leukemia
 
 
NCT00423826: Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

No Longer Available
N/A
US
Busulfan, Busulfex®, Myleran®, Cytarabine, DepoCyt(TM), Liposomal Ara-C, Fludarabine phosphate, Fludara, mycophenolate mofetil, Cellcept, tacrolimus, Advagraf, Prograf, Protopic, allogeneic hematopoietic stem cell transplantation, umbilical cord blood transplantation, total-body irradiation
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
01/15
01/15
EAP, NCT02197650: Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase

No Longer Available
N/A
Europe
suspension of erythrocytes encapsulating L-asparaginase, GRASPA®, eryaspase
ERYtech Pharma
Acute Lymphoblastic Leukemia
 
 

Download Options